TrialClinical and experimental immunology2023

Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function.

Alex D Hakim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.